Hepatitis C Therapy – Related Haematological Side Effects are Associated with Treatment Outcome / Hematološka Neželjena Dejstva Terapije Hepatitisa C Su Povezana Sa Ishodom Lecenja

Published Online: Apr 14, 2016

Page range: 9 - 14

Received: Apr 21, 2015

Accepted: Jul 06, 2015

DOI: https://doi.org/10.1515/sjecr-2015-0036

Keywords

chronic hepatitis C, pegylated interferon alpha 2a, ribavirin, anaemia, thrombocytopenia, leucopoenia, neutropenia

© 2016

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.